Beyond the HPA axis: Progesterone-derived neuroactive steroids in human stress and emotion

Frontiers in Endocrinology

Volumn 2, Issue AUG, 2010, Pages

  Wirth, Michelle M ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

3 hydroxy 5 pregnan 20 one; Affiliation; Allopregnanolone; Progesterone; Social motivation; Stress

Indexed keywords

EID: 84865580017     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00019     Document Type: Review

References (130)

1. Abercrombie, H. C., Giese-Davis, J., Sephton,S.,Epel,E. S.,Turner-Cobb, J. M., and Spiegel, D. (2004). Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 29, 1082-1092.
2. Akil, H., Watson, S. J., Young, E., Lewis, M. E., Khachaturian, H., and Walker, J. M. (1984). Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7, 223-255.
3. Akk, G., Bracamontes, J., and Steinbach, J. H. (2004a). Activation of GABA(A) receptors containing the alpha4 subunit by GABA and pentobarbital. J. Physiol. (Lond.) 556, 387-399.
4. Akk, G., Bracamontes, J. R., Covey, D. F., Evers, A., Dao, T., and Steinbach, J. H. (2004b). Neuroactive steroids have multiple actions to potentiate GABAA receptors. J. Physiol. (Lond.) 558, 59-74.
5. Alomary, A. A., Fitzgerald, R. L., and Purdy, R. H. (2001). Neurosteroid analysis. Int. Rev. Neurobiol. 46, 97-115.
6. Amin,Z.,Mason,G. F.,Cavus,I.,Krystal, J. H., Rothman, D. L., and Epperson, C. N. (2006). The interaction of neuroactive steroids and GABA in the development of neuropsychiatric disorders in women. Pharmacol. Biochem. Behav. 84, 635-643.
7. Andreen, L., Nyberg, S., Turkmen, S., van Wingen, G., Fernandez, G., and Backstrom, T. (2009). Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators. Psychoneuroendocrinology 34, 1121-1132.
8. Auger, C. J., and Forbes-Lorman, R. M. (2008). Progestin receptor-mediated reduction of anxiety-like behavior in male rats. PLoS ONE 3, e3606. doi: 10.1371/journal.pone.0003606
9. Baghai, T. C., di Michele, F., Schule, C., Eser, D., Zwanzger, P., Pasini, A., Romeo, E., and Rupprecht, R. (2005). Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression. Neuropsychopharmacology 30, 1181-1186.
10. Barbaccia, M. L., Roscetti, G., Trabucchi, M., Purdy, R. H., Mostallino, M. C., Concas,A., and Biggio, G. (1997). The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br. J. Pharmacol. 120, 1582-1588.
11. Barbaccia, M. L., Serra, M., Purdy, R. H., and Biggio, G. (2001). Stress and neuroactive steroids. Int. Rev. Neurobiol. 46, 243-272.
12. Bicikova, M., Dibbelt, L., Hill, M., Hampl, R., and Starka, L. (1998). Allopregnanolone in women with premenstrual syndrome. Horm. Metab. Res. 30, 227-230.
13. Bitran, D., Hilvers, R. J., and Kellogg, C. K. (1991). Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res. 561, 157-161.
14. Bitran, D., Shiekh, M., and McLeod, M. (1995). Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J. Neuroendocrinol. 7, 171-177.
15. Boury, J. M., Larkin, K. T., and Krummel, D. A. (2004). Factors related to postpartum depressive symptoms in low-income women. Women Health 39, 19-34.
16. Brambilla, F., Biggio, G., Pisu, M. G., Bellodi, L., Perna, G., BogdanovichDjukic, V., Purdy, R. H., and Serra, M. (2003). Neurosteroid secretion in panic disorder. Psychiatry Res 118, 107-116.
17. Brot,M. D.,Akwa,Y.,Purdy,R. H.,Koob, G. F., and Britton, K. T. (1997). The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors. Eur. J. Pharmacol. 325, 1-7.
18. Brown, S. L., and Brown, R. M. (2011). Activation of the caregiving system: progesterone as a possible mechanism for linking compassionate behavior to enhanced stress regulation. Paper Presented at Association for Psychological Science's 23rd Annual Meeting, Washington, DC.
19. Brown, S. L., Fredrickson, B. L., Wirth, M. M., Poulin, M. J., Meier, E. A., Heaphy, E. D., Cohen, M. D., and Schultheiss, O. C. (2009). Social closeness increases salivary progesterone in humans. Horm. Behav. 56, 108-111.
20. Carter, C. S., Williams, J. R., Witt, D. M., and Insel, T. R. (1992). Oxytocin and social bonding. Ann. N. Y. Acad. Sci. 652, 204-211.
21. Celotti, F., Melcangi, R. C., and Martini,L. (1992). The 5 alpha-reductase in the brain: molecular aspects and relation to brain function. Front. Neuroendocrinol. 13, 163-215.
22. Cheney, D. L., Uzunov, D., Costa, E., and Guidotti, A. (1995). Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J. Neurosci. 15, 4641-4650.
23. Childs, E., and de Wit, H. (2009). Hormonal, cardiovascular, and subjective responses to acute stress in smokers. Psychopharmacology (Berl.) 203, 1-12.
24. Childs, E., Dlugos, A., and De Wit, H. (2010a). Cardiovascular, hormonal, and emotional responses to the TSST in relation to sex and menstrual cycle phase. Psychophysiology 47, 550-559.
25. Childs, E., Van Dam, N. T., and de Wit, H. (2010b). Effects of acute progesterone administration upon responses to acute psychosocial stress in men. Exp. Clin. Psychopharmacol. 18, 78-86.
26. Cohen, J., and Cohen, P. (1983). Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. Hillsdale, NJ: Erlbaum.
27. Compagnone, N. A., and Mellon, S. H. (2000). Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21, 1-56.
28. Coyne, J. C., Rohrbaugh, M. J., Shoham, V., Sonnega, J. S., Nicklas, J. M., and Cranford, J. A. (2001). Prognostic importance of marital quality for survival of congestive heart failure. Am. J. Cardiol. 88, 526-529.
29. da Silva Torres, I. L., Cucco, S. N., Bassani, M., Duarte, M. S., Silveira, P. P., Vasconcellos, A. P., Tabajara, A. S., Dantas, G., Fontella, F. U., Dalmaz, C., and Ferreira, M. B. (2003). Long-lasting delayed hyperalgesia after chronic restraint stress in rats-effect of morphine administration. Neurosci. Res. 45, 277-283.
30. de Kloet, E. R., Oitzl, M. S., and Joels, M. (1999). Stress and cognition: are corticosteroids good or bad guys?Trends Neurosci. 22, 422-426.
31. de Quervain, D. J., Aerni, A., Schelling, G., and Roozendaal, B. (2009). Glucocorticoids and the regulation of memory in health and disease. Front. Neuroendocrinol. 30, 358-370.
32. de Wit, H., Schmitt, L., Purdy, R., and Hauger, R. (2001). Effects of acute progesterone administration in healthy postmenopausal women and normally-cycling women. Psychoneuroendocrinology 26, 697-710.
33. Depue, R. A., and Morrone-Strupinsky, J. V. (2005). A neurobehavioral model of affiliative bonding: implications for conceptualizing a human trait of affiliation. Behav. Brain Sci. 28, 313-350; discussion 350-395.
34. Dickerson, S. S., and Kemeny, M. E. (2004). Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol. Bull. 130, 355-391.
35. Dong, E., Matsumoto, K., Uzunova, V., Sugaya, I., Takahata, H., Nomura, H., Watanabe, H., Costa, E., and Guidotti, A. (2001). Brain 5alphadihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc. Natl. Acad. Sci. U.S.A. 98, 2849-2854.
36. Droogleever Fortuyn, H. A., van Broekhoven, F., Span, P. N., Backstrom, T., Zitman, F. G., and Verkes, R. J. (2004). Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology 29, 1341-1344.
37. Dubrovsky, B. (2006). Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacol. Biochem. Behav. 84, 644-655.
38. Epperson, C. N., Gueorguieva, R., Czarkowski, K. A., Stiklus, S., Sellers, E., Krystal, J. H., Rothman, D. L., and Mason,G. F. (2006). Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology (Berl.) 186, 425-433.
39. Epperson, C. N., Haga, K., Mason, G. F., Sellers, E., Gueorguieva, R., Zhang, W., Weiss, E., Rothman, D. L., and Krystal, J. H. (2002). Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch. Gen. Psychiatry 59, 851-858.
40. Eser, D., Romeo, E., Baghai, T. C., di Michele, F., Schule, C., Pasini, A., Zwanzger, P., Padberg, F., and Rupprecht, R. (2006). Neuroactive steroids as modulators of depression and anxiety. Neuroscience 138, 1041-1048.
41. Fleming, A. S., Steiner, M., and Corter, C. (1997). Cortisol, hedonics, and maternal responsiveness in human mothers. Horm. Behav. 32, 85-98.
42. Freeman, E. W., Purdy, R. H., Coutifaris, C., Rickels, K., and Paul, S. M. (1993). Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers. Neuroendocrinology 58, 478-484.
43. Friess, E., Tagaya, H., Trachsel, L., Holsboer, F., and Rupprecht, R. (1997). Progesterone-induced changes in sleep in male subjects. Am. J. Physiol. 272, E885-E891.
44. Frye, C. A., Bayon, L. E., Pursnani, N. K., and Purdy, R. H. (1998). The neurosteroids,progesterone and 3alpha,5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res. 808, 72-83.
45. Frye, C. A., Rhodes, M. E., Petralia, S. M., Walf, A. A., Sumida, K., and Edinger, K. L. (2006). 3alphahydroxy-5alpha-pregnan-20-one in the midbrain ventral tegmental area mediates social, sexual, and affective behaviors. Neuroscience 138, 1007-1014.
46. Frye, C. A., Walf, A. A., Rhodes, M. E., and Harney, J. P. (2004). Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5 alpha-reductase. Brain Res. 1004, 116-124.
47. Genazzani, A. R., Petraglia, F., Bernardi, F., Casarosa, E., Salvestroni, C., Tonetti, A., Nappi, R. E., Luisi, S., Palumbo, M., Purdy, R. H., and Luisi, M. (1998). Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J. Clin. Endocrinol. Metab. 83, 2099-2103.
48. Girdler, S. S., and Klatzkin, R. (2007). Neurosteroids in the context of stress: implications for depressive disorders. Pharmacol. Ther. 116, 125-139.
49. Girdler, S. S., Straneva, P. A., Light, K. C., Pedersen, C. A., and Morrow, A. L. (2001). Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol. Psychiatry 49, 788-797.
50. Guidotti, A., Dong, E., Matsumoto, K., Pinna, G., Rasmusson, A. M., and Costa, E. (2001). The sociallyisolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders. Brain Res. Brain Res. Rev. 37, 110-115.
51. Harrison, N. L., Majewska, M. D., Harrington, J. W., and Barker, J. L. (1987). Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex. J. Pharmacol. Exp. Ther. 241, 346-353.
52. Harrison, N. L., and Simmonds, M. A. (1984). Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 323, 287-292.
53. Hashimoto, K., Murakami, K., Takao, T., Makino, S., Sugawara, M., and Ota, Z. (1989). Effect of acute ether or restraint stress on plasma corticotropin-releasing hormone, vasopressin and oxytocin levels in the rat. Acta Med. Okayama 43, 161-167.
54. Heinrichs, M., Baumgartner, T., Kirschbaum, C., and Ehlert, U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 54, 1389-1398.
55. House, J. S., Landis, K. R., and Umberson, D. (1988). Social relationships and health. Science 241, 540-545.
56. Insel, T. R. (1997). A neurobiological basis of social attachment. Am. J. Psychiatry 154, 726-735.
57. Joels, M. (2006). Corticosteroid effects in the brain: U-shape it. Trends Pharmacol. Sci. 27, 244-250.
58. Johansson, I. M., Birzniece, V., Lindblad, C., Olsson, T., and Backstrom, T. (2002). Allopregnanolone inhibits learning in the Morris water maze. Brain Res. 934, 125-131.
59. Kalin, N. H., Shelton, S. E., and Barksdale, C. M. (1988). Opiate modulation of separation-induced distress in non-human primates. Brain Res. 440, 285-292.
60. Kalin, N. H., Shelton, S. E., and Lynn, D. E. (1995). Opiate systems in mother and infant primates coordinate intimate contact during reunion. Psychoneuroendocrinology 20, 735-742.
61. Karavolas, H. J., Hodges, D. R., and O'Brien, D. J. (1979). In vivo uptake and metabolism of [3H]progesterone and [3H]5 alpha-dihydroprogesterone by rat CNS and anterior pituitary: tissue concentration of progesterone itself or metabolites? J. Steroid Biochem. 11, 863-872.
62. Kask, K., Backstrom, T., Nilsson, L. G., and Sundstrom-Poromaa, I. (2008). Allopregnanolone impairs episodic memory in healthy women. Psychopharmacology (Berl.) 199, 161-168.
63. Khisti, R. T., Chopde, C. T., and Jain,S. P. (2000).Antidepressant-like effect of the neurosteroid 3alphahydroxy-5alpha-pregnan-20-one in mice forced swim test. Pharmacol. Biochem. Behav. 67, 137-143.
64. Kim, Y. S., Zhang, H., and Kim, H. Y. (2000). Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography/electron capture negative chemical ionization mass spectrometry. Anal. Biochem. 277, 187-195.
65. Kirschbaum, C., Pirke, K. M., and Hellhammer, D. H. (1993). The 'Trier Social Stress Test' a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28, 76-81.
66. Klatzkin, R. R., Morrow, A. L., Light, K. C., Pedersen, C. A., and Girdler, S. S. (2006a). Associations of histories of depression and PMDD diagnosis with allopregnanolone concentrations following the oral administration of micronized progesterone. Psychoneuroendocrinology 31, 1208-1219.
67. Klatzkin, R. R., Morrow, A. L., Light, K. C., Pedersen, C. A., and Girdler, S. S. (2006b). Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women. Biol. Psychol. 71, 2-11.
68. Ladurelle, N., Eychenne, B., Denton, D., Blair-West, J., Schumacher, M., Robel, P., and Baulieu, E. (2000). Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse. Brain Res. 858, 371-379.
69. Lambert, J. J., Belelli, D., Peden, D. R., Vardy, A. W., and Peters, J. A. (2003). Neurosteroid modulation of GABAA receptors. Prog. Neurobiol. 71, 67-80.
70. Longone, P., Rupprecht, R., Manieri, G. A., Bernardi, G., Romeo, E., and Pasini, A. (2008). The complex roles of neurosteroids in depression and anxiety disorders. Neurochem. Int. 52, 596-601.
71. Lupien, S. J., Maheu, F., Tu, M., Fiocco, A., and Schramek, T. E. (2007). The effects of stress and stress hormones on human cognition: implications for the field of brain and cognition. Brain Cogn. 65, 209-237.
72. Magnaghi, V. (2007). GABA and neuroactive steroid interactions in glia: new roles for old players? Curr. Neuropharmacol. 5, 47-64.
73. Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., and Paul, S. M. (1986). Steroid hormone metabolites are barbituratelike modulators of the GABA receptor. Science 232, 1004-1007.
74. Maner, J. K., Miller, S. L., Schmidt, N. B., and Eckel, L. A. (2010). The endocrinology of exclusion: rejection elicits motivationally tuned changes in progesterone. Psychol. Sci. 21, 581-588.
75. Marx, C. E., Stevens, R. D., Shampine, L. J., Uzunova, V., Trost, W. T., Butterfield, M. I., Massing, M. W., Hamer, R. M., Morrow, A. L., and Lieberman, J. A. (2006). Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics. Neuropsychopharmacology 31, 1249-1263.
76. McAdams, D. P., and Vaillant, G. E. (1982). Intimacy motivation and psychosocial adjustment: a longitudinal study. J. Pers. Assess. 46, 586.
77. McClelland, D. C. (1989). Motivational factors in health and disease. Am. Psychol. 44, 675.
78. Miczek, K. A., Fish, E. W., and De Bold, J. F. (2003). Neurosteroids, GABAA receptors, and escalated aggressive behavior. Horm. Behav. 44, 242-257.
79. Morrow, A. L. (2007). Recent developments in the significance and therapeutic relevance of neuroactive steroids Introduction to the special issue. Pharmacol. Ther. 116, 1-6.
80. Nelson,R. J. (2005)."Stress,"in An Introduction to Behavioral Endocrinology, Anonymous (Sunderland, MA: Sinauer Associates), 669720.
81. Norberg, L., Wahlstrom, G., and Backstrom, T. (1987). The anaesthetic potency of 3 alpha-hydroxy5 alpha-pregnan-20-one and 3 alpha-hydroxy-5 beta-pregnan-20one determined with an intravenous EEG-threshold method in male rats. Pharmacol. Toxicol. 61, 4247.
82. N-Wihlback, A. C., SundstromPoromaa, I., and Backstrom, T. (2006). Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. Psychopharmacology (Berl.) 186, 388401.
83. Onaka, T. (2004). Neural pathways controlling central and peripheral oxytocin release during stress. J. Neuroendocrinol. 16, 308312.
84. Parizek, A., Hill, M., Kancheva, R., Havlikova, H., Kancheva, L., Cindr, J., Paskova, A., Pouzar, V., Cerny, I., Drbohlav,P.,Hajek,Z.,and Starka,L. (2005). Neuroactive pregnanolone isomers during pregnancy. J. Clin. Endocrinol. Metab. 90, 395403.
85. Patchev,V.K.,Hassan,A.H.,Holsboer,D. F.,andAlmeida,O.F.(1996).Theneurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoidlike effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 15, 533540.
86. Patchev, V. K., Shoaib, M., Holsboer, F., and Almeida, O. F. (1994). The neurosteroid tetrahydroprogesterone counteracts corticotropinreleasing hormone-induced anxiety and alters the release and gene expression of corticotropinreleasing hormone in the rat hypothalamus. Neuroscience 62, 265271.
87. Paul, S. M., and Purdy, R. H. (1992). Neuroactive steroids. FASEB J. 6, 23112322.
88. Pearson Murphy, B. E., and Allison, C. M. (2000). Determination of progesterone and some of its neuroactive ring A-reduced metabolites in human serum. J. Steroid Biochem. Mol. Biol. 74, 137142.
89. Pisu, M. G., and Serra, M. (2004). Neurosteroids and neuroactive drugs in mental disorders. Life Sci. 74, 31813197.
90. Porcu, P., O'Buckley, T. K., Alward, S. E., Marx, C. E., Shampine, L. J., Girdler, S. S., and Morrow, A. L. (2009). Simultaneous quantification of GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in human and rat serum. Steroids 74, 463473.
91. Prince, M. J., Harwood, R. H., Blizard, R. A., Thomas, A., and Mann, A. H. (1997). Social support deficits, loneliness and life events as risk factors for depression in old age. The Gospel Oak Project VI. Psychol. Med. 27, 323332.
92. Purdy, R. H., Morrow, A. L., Moore, P. H. Jr., and Paul, S. M. (1991). Stressinduced elevations of gammaaminobutyric acid type A receptoractive steroids in the rat brain. Proc. Natl. Acad. Sci. U.S.A. 88, 45534557.
93. Rasmusson, A. M., Pinna, G., Paliwal, P., Weisman, D., Gottschalk, C., Charney, D., Krystal, J., and Guidotti, A. (2006). Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol. Psychiatry 60, 704713.
94. Ribeiro, S. C., Kennedy, S. E., Smith, Y. R., Stohler, C. S., and Zubieta, J. K. (2005). Interface of physical and emotional stress regulation through the endogenous opioid system and mu-opioid receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 12641280.
95. Robles, T. F., and Kiecolt-Glaser, J. K. (2003). The physiology of marriage: pathways to health. Physiol. Behav. 79, 409416.
96. Rodriguez-Landa, J. F., Contreras, C. M., Bernal-Morales, B., GutierrezGarcia, A. G., and Saavedra, M. (2007). Allopregnanolone reduces immobility in the forced swimming test and increases the firing rate of lateral septal neurons through actions on the GABAA receptor in the rat. J. Psychopharmacol. 21, 7684.
97. Romeo, E., Strohle, A., Spalletta, G., di Michele, F., Hermann, B., Holsboer, F., Pasini, A., and Rupprecht, R. (1998). Effects of antidepressant treatment on neuroactive steroids in major depression. Am. J. Psychiatry 155, 910913.
98. Rupprecht, R. (1997). The neuropsychopharmacological potential of neuroactive steroids. J. Psychiatr. Res. 31, 297314.
99. Sapolsky, R. M. (2002). "Endocrinology of the stress-response," in Behavioral Endocrinology,edsJ.B. Becker,S.M.Breedlove,D.Crews, and M. M. McCarthy (Cambridge, MA: MIT Press), 409450
100. Schule, C., Di Michele, F., Baghai, T., Romeo, E., Bernardi, G., Zwanzger, P., Padberg, F., Pasini, A., and Rupprecht, R. (2004). Neuroactive steroids in responders and nonresponders to sleep deprivation. Ann. N. Y. Acad. Sci. 1032, 216223.
101. Schultheiss, O. C., Dargel, A., and Rohde, W. (2003). Implicit motives and gonadal steroid hormones: effects of menstrual cycle phase, oral contraceptive use, and relationship status. Horm. Behav. 43, 293301.
102. Schultheiss, O. C., Wirth, M. M., and Stanton, S. J. (2004). Effects of affiliation and power motivation arousal on salivary progesterone and testosterone. Horm. Behav. 46, 592599.
103. Serra, M., Sanna, E., Mostallino, M. C., and Biggio, G. (2007). Social isolation stress and neuroactive steroids. Eur. Neuropsychopharmacol. 17, 111.
104. Shu, H. J., Eisenman, L. N., Jinadasa, D., Covey, D. F., Zorumski, C. F., and Mennerick, S. (2004). Slow actions of neuroactive steroids at GABAA receptors. J. Neurosci. 24, 6667-6675.
105. Silvers, J. M., Tokunaga, S., Berry, R. B., White, A. M., and Matthews, D. B. (2003). Impairments in spatial learning and memory: ethanol, allopregnanolone, and the hippocampus. Brain Res. Brain Res. Rev. 43, 275284.
106. Smith, D. M. (2011). Helping others as a protective factor that promotes physiological resilience to stress. Paper Presented at Association for Psychological Science's 23rd Annual Meeting, Washington, DC.
107. Soderpalm, A. H., Lindsey, S., Purdy, R. H., Hauger, R., and Wit de, H. (2004). Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology 29, 339354.
108. Strohle, A., Romeo, E., Hermann, B., Pasini, A., Spalletta, G., di Michele, F., Holsboer, F., and Rupprecht, R. (1999). Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol. Psychiatry 45, 274277.
109. Sundstrom, I., Andersson, A., Nyberg, S., Ashbrook, D., Purdy, R. H., and Backstrom, T. (1998). Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67, 126138.
110. Taylor, S. E., Klein, L. C., Lewis, B. P., Gruenewald, T. L., Gurung, R. A., and Updegraff, J. A. (2000). Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol. Rev. 107, 411429.
111. Temkin-Greener, H., Bajorska,A., Peterson, D. R., Kunitz, S. J., Gross, D., Williams, T. F., and Mukamel, D. B. (2004). Social support and riskadjusted mortality in a frail older population. Med. Care 42, 779788.
112. Timby, E., Balgard, M., Nyberg, S., Spigset, O., Andersson, A., Porankiewicz-Asplund, J., Purdy, R. H., Zhu, D., Backstrom, T., and Poromaa, I. S. (2006). Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl.) 186, 414424.
113. Uvnas-Moberg, K. (1998a). Antistress pattern induced by oxytocin. News Physiol. Sci. 13, 2225.
114. Uvnas-Moberg, K. (1998b). Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology 23, 819835.
115. Uvnas-Moberg, K., Ahlenius, S., Hillegaart, V., and Alster, P. (1994). High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol. Biochem. Behav. 49, 101106.
116. Uzunova, V., Sampson, L., and Uzunov, D. P. (2006). Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl.) 186, 351361.
117. Uzunova, V., Sheline, Y., Davis, J. M., Rasmusson, A., Uzunov, D. P., Costa, E., and Guidotti, A. (1998). Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. U.S.A. 95, 32393244.
118. Vallee, M., Rivera, J. D., Koob, G. F., Purdy, R. H., and Fitzgerald, R. L. (2000). Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal. Biochem. 287, 153166.
119. van Broekhoven, F., and Verkes, R. J. (2003). Neurosteroids in depression: areview.Psychopharmacology (Berl.) 165, 97110.
120. van Wingen, G., van Broekhoven, F., Verkes, R. J., Petersson, K. M., Backstrom, T., Buitelaar, J., and Fernandez, G. (2007). How progesterone impairs memory for biologically salient stimuli in healthy young women. J. Neurosci. 27, 1141611423.
121. van Wingen, G. A., van Broekhoven, F., Verkes, R. J., Petersson, K. M., Backstrom, T., Buitelaar, J. K., and Fernandez, G. (2008). Progesterone selectively increases amygdala reactivity in women. Mol. Psychiatry 13, 325333.
122. Wang, M. D., Wahlstrom, G., and Backstrom, T. (1997). The regional brain distribution of the neurosteroids pregnenolone and pregnenolone sulfate following intravenous infusion. J. Steroid Biochem. Mol. Biol. 62, 299306.
123. Wieland, S., Lan, N. C., Mirasedeghi, S., and Gee, K. W. (1991). Anxiolytic activity of the progesterone metaboite 5 alpha-pregnan-3 alphao1-20one. Brain Res. 565, 263268.
124. Wikipedia. (2011). Progesterone. Available at: http://en.wikipedia.org/ wiki/Progesterone [July 18, 2011].
125. Wirth, M. M., Meier, E. A., Fredrickson, B. L., and Schultheiss, O. C. (2007). Relationship between salivary cortisol and progesterone levels in humans. Biol. Psychol. 74, 104107.
126. Wirth, M. M., and Schultheiss, O. C. (2006). Effects of affiliation arousal (hope of closeness) and affiliation stress (fear of rejection) on progesterone and cortisol. Horm. Behav. 50, 786795.
127. Wolthers, B. G., and Kraan, G. P. (1999). Clinical applications of gas chromatography and gas chromatography-mass spectrometry of steroids. J. Chromatogr. A 843, 247274.
128. Zeldow, P. B., Daugherty, S. R., and McAdams, D. P. (1988). Intimacy, power, and psychological well-being in medical students. J. Nerv. Ment. Dis. 176, 182.
129. Zhu, D., Wang, M. D., Backstrom, T., and Wahlstrom, G. (2001). Evaluation and comparison of the pharmacokinetic and pharmacodynamic properties of allopregnanolone and pregnanolone at induction of anaesthesia in the male rat. Br. J. Anaesth. 86, 403412.
130. Zimmerberg, B., Brunelli, S. A., and Hofer, M. A. (1994). Reduction of rat pup ultrasonic vocalizations by the neuroactive steroid allopregnanolone. Pharmacol. Biochem. Behav. 47, 735738.